Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:RANI News 31 October 2025 - 28 November 2025

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) is finishing November with quieter headlines but still very lively trading. As of today, 28 November 2025, the biotech micro‑cap is consolidating after its spectacular October surge on the back of a transformative collaboration with Japan’s Chugai Pharmaceutical and a $60.3 million private placement that extended its cash runway into 2028. Reuters+2Stock Titan+2 Crucially for anyone looking for “RANI stock news today”: Below is a detailed, Google News–friendly breakdown of where RANI stands today, what’s driving sentiment, and what to watch next. RANI stock price on 28 November 2025 Across major data providers, RANI
28 November 2025
··
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts

Updated: November 19, 2025 Rani Therapeutics Holdings (NASDAQ: RANI) finished Wednesday, Nov. 19, 2025 at $1.75, down from $1.86 on Tuesday. The stock opened at $1.83, traded between $1.70–$1.90, and moved ~2.5M shares on the day, according to end‑of‑day pricing data. Yahoo Finance Today’s trading at a glance (19.11.2025) Was there fresh company news today?As of publication on Nov. 19, no new Rani press releases or material company updates were posted today. The most recent company news remains the Q3 2025 results issued Nov. 6. Rani Therapeutics, LLCLikewise, no new SEC filings were posted today; the latest notable filing was
20 November 2025
··
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Rockets 51% on Obesity Pill Breakthrough and $1B Pharma Deal

Stock Price and Recent Performance RANI has seen explosive moves this month. As of the Oct 31 close, Rani Therapeutics stock was $2.20 (up $0.75, +51.7%)stockanalysis.com. This follows a monumental rally: on Oct 17, RANI nearly tripled from ~$0.47 to an intraday high of $2.39 (+248%)ts2.techstockanalysis.com after the company announced the Chugai collaboration and financing. Even after that spike, RANI remained volatile – it spent mid-October around $1.50–2.50, briefly crossing Nasdaq’s $1 bid threshold and greatly lifting its market cap. Volume has been extremely high: for example, ~172 million shares traded on Oct 20 and ~124 million on Oct 21stockanalysis.com, versus an average of only
31 October 2025
··

Stock Market Today

Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

8 February 2026
Boeing shares closed up 2.6% at $243.03 Friday, buoyed by reports of possible major aircraft orders from Saudi Arabia and India. India’s trade minister said a $70–80 billion Boeing deal could be signed by March. Supply-chain delays and regulatory scrutiny remain key risks. Boeing’s chief engineer sold over 10,000 shares earlier in the week.
Verizon stock snaps seven-day winning streak — what to watch for VZ into the new week

Verizon stock snaps seven-day winning streak — what to watch for VZ into the new week

8 February 2026
Verizon shares fell 1.7% to $46.31 on Friday, ending a seven-day rally and lagging a broad market rebound. The drop follows a leadership shakeup in the consumer unit, with Sowmyanarayan Sampath stepping down and Alfonso Villanueva named interim chief. Investors await delayed U.S. jobs and inflation data next week, which could affect rate-sensitive stocks.
Go toTop